204 related articles for article (PubMed ID: 32054916)
1. An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity.
Peytam F; Adib M; Shourgeshty R; Firoozpour L; Rahmanian-Jazi M; Jahani M; Moghimi S; Divsalar K; Faramarzi MA; Mojtabavi S; Safari F; Mahdavi M; Foroumadi A
Sci Rep; 2020 Feb; 10(1):2595. PubMed ID: 32054916
[TBL] [Abstract][Full Text] [Related]
2. In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.
Chaudhry F; Naureen S; Huma R; Shaukat A; Al-Rashida M; Asif N; Ashraf M; Munawar MA; Khan MA
Bioorg Chem; 2017 Apr; 71():102-109. PubMed ID: 28160945
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
Peytam F; Takalloobanafshi G; Saadattalab T; Norouzbahari M; Emamgholipour Z; Moghimi S; Firoozpour L; Bijanzadeh HR; Faramarzi MA; Mojtabavi S; Rashidi-Ranjbar P; Karima S; Pakraad R; Foroumadi A
Sci Rep; 2021 Jun; 11(1):11911. PubMed ID: 34099819
[TBL] [Abstract][Full Text] [Related]
4. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B
Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.
Kashtoh H; Muhammad MT; Khan JJ; Rasheed S; Khan A; Perveen S; Javaid K; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Bioorg Chem; 2016 Apr; 65():61-72. PubMed ID: 26874344
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study.
Azimi F; Azizian H; Najafi M; Hassanzadeh F; Sadeghi-Aliabadi H; Ghasemi JB; Ali Faramarzi M; Mojtabavi S; Larijani B; Saghaei L; Mahdavi M
Bioorg Chem; 2021 Sep; 114():105127. PubMed ID: 34246971
[TBL] [Abstract][Full Text] [Related]
10. Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.
Rehman TU; Riaz S; Khan IU; Ashraf M; Bajda M; Gawalska A; Yar M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29194730
[TBL] [Abstract][Full Text] [Related]
11. Hydrazinyl arylthiazole based pyridine scaffolds: Synthesis, structural characterization, in vitro α-glucosidase inhibitory activity, and in silico studies.
Ali F; Khan KM; Salar U; Taha M; Ismail NH; Wadood A; Riaz M; Perveen S
Eur J Med Chem; 2017 Sep; 138():255-272. PubMed ID: 28672278
[TBL] [Abstract][Full Text] [Related]
12. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in silico screening of 2-amino-4-aryl-6-(phenylthio) pyridine-3,5-dicarbonitriles as novel α-glucosidase inhibitors.
Ali M; Khan KM; Mahdavi M; Jabbar A; Shamim S; Salar U; Taha M; Perveen S; Larijani B; Faramarzi MA
Bioorg Chem; 2020 Jul; 100():103879. PubMed ID: 32413625
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: Development of highly active 5,6-disubstituted derivatives.
Sun H; Ding W; Song X; Wang D; Chen M; Wang K; Zhang Y; Yuan P; Ma Y; Wang R; Dodd RH; Zhang Y; Lu K; Yu P
Bioorg Med Chem Lett; 2017 Aug; 27(15):3226-3230. PubMed ID: 28651984
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
16. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
Gong Z; Xie Z; Qiu J; Wang G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
